Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease

21 Nov 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dialysis and Renal Disease Management
Share to Erythropoietin and Anemia Treatment
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24289887
DOI: 10.1016/j.jns.2013.11.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's diseasePMID 24289887Read ↗

Clinical trials test the safety of stem-cell therapy for Parkinson’s diseaseSemantic proximity Read ↗

Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s diseaseSemantic proximity Read ↗

Ropinirole hydrochloride for amyotrophic lateral sclerosis: A single-center, randomized feasibility, double-blind, placebo-controlled trialSemantic proximity Read ↗

GDNF clinical trials for Parkinson’s disease: a critical human dimensionSemantic proximity Read ↗

Stem cell-based therapy for Parkinson's disease with a focus on human endometrium-derived mesenchymal stem cells.Semantic proximity Read ↗

Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01Semantic proximity Read ↗

Expression of α-synuclein, a presynaptic protein implicated in Parkinson’s disease, in erythropoietic lineageSemantic proximity Read ↗

Therapy in Huntington’s Disease: Where Are We?Semantic proximity Read ↗

[Treatments for Parkinson's Disease -Essential Knowledge for General Physicians - Topics: III. Recommended Usage of New Antiparkinson Drugs].Semantic proximity Read ↗

Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model.Semantic proximity Read ↗

Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agentsSemantic proximity Read ↗

Graft-Induced Dyskinesias in Parkinson's Disease: What Is It All About?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.